You are here




Coverage of the latest news and updates from the field of stem cells.

July 17, 2014

Gene-editing techniques being used on stem cells do not increase the overall occurrence of mutations in the cells, according to a new study by scientists at Salk Institute.

July 16, 2014

An overwhelming majority of Americans support stem cell research, according to the results of an online survey released July 10 by Cord Blood Registry® (CBR) to coincide with National Cord Blood Awareness Month.

July 15, 2014

A mucous-producing, nose-like growth at the site of a stem cell transplant has been removed from a woman’s spine.

July 11, 2014

Half the patients in a clinical trial were able to safely stop immunosuppressant medication following a modified blood stem cell transplant for severe sickle cell disease, according to a study conducted at the National Institutes of Health (NIH) Clinical Center in Bethesda, Maryland.

July 9, 2014

About 7 days after conception, something remarkable occurs in the clump of cells that will eventually become a new human being. They start to specialize into any of the roughly 200 cell types that exist in people.

July 8, 2014

Two men with HIV may have been cured after they received stem cell transplants to treat lymphoma, a type of blood cancer.

July 8, 2014

Researchers have identified a way to enhance regrowth of human corneal tissue to restore vision, using a molecule known as ABCB5 that acts as a marker for hard-to-find limbal stem cells.

July 1, 2014

Osiris Therapeutics, Inc., has announced that a report of the results of its multicenter randomized, controlled clinical trial comparing the safety and effectiveness of Grafix to control in patients with chronic diabetic foot ulcers (DFUs) has been accepted for publication in the Internationa

July 1, 2014

Scientists have discovered a new class of lipids in leukemia cells that are detected by a unique group of immune cells. By recognizing the lipids, the immune cells stimulate an immune response to destroy the leukemia cells and suppress their growth.  

July 1, 2014

Calimmune has been given the go ahead to treat a second group of patients in a phase I/II clinical trial testing its gene-based stem cell therapy for HIV.

The company was given the green light to move ahead following a review of safety data by the Data Safety Monitoring Board (DSMB).